Atlas Trials

A Pharmacokinetic Study of HDM1005 Injection in Participants With Impaired Renal Function and Healthy Participants

Clinical trial NCT07559240 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07559240
Sponsor
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
OverweightObese
Start date
2026-05-15
Primary completion
2026-06-12
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.